RxDoctor Payments Data

Sean Yates, MD

Blood Banking & Transfusion Medicine · Dallas, TXNPI 1770873200

Payments from drug & device makers

What this record shows

8 manufacturers reported payments, led by Siemens Medical Solutions USA, Inc. at 58.6% of the total. Reporting peaked in 2023 at $5,332 and has fallen 99.2% since, to $42 in 2025.

$8,035in general payments, 2019–2025

Across 56 payments — averaging $143.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Siemens Medical Solutions USA, Inc.$5K
  • Hemosonics LLC$2K
  • Sanofi$279
  • Gilead$149
  • Werfen USA LLC$129
  • Sanofi-aventis U.S. LLC$128
  • plus $155 from 2 others
$154,046in research payments, 2019–2025

Across 10 payments — averaging $15,405 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Diagnostica Stago, Inc$90K
  • Hemosonics LLC$64K

What the payments were for

  • Travel & lodging$4,27753%
  • Food & beverage$3,75847%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Siemens Medical Solutions USA, Inc.12$4,707
Hemosonics LLC35$2,488
Sanofi4$279
Gilead1$149
Werfen USA LLC1$129
Sanofi-aventis U.S. LLC1$128
Carter Bloodcare1$113
Vertex1$42

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few blood banking & transfusion medicine providers in Texasto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$1,483
Medicare patients
22
Services billed
68

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other blood banking & transfusion medicine in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →